Fig. 2.
Cumulative incidence estimates of the probability of nonrelapse mortality.
Estimates are displayed as a function of exposure to the cyclophosphamide metabolite, CEPM, expressed as the lowest (first) quartile through the highest (fourth) quartile of AUCCEPM.
